Low molecular weight heparin as thromboprophylaxis throughout pregnancy in heritable thrombophilic women.
Boda
Z
Z
László
P
P
Pfliegler
G
G
Tornai
I
I
Rejtö
L
L
Schlammadinger
A
A
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011256:Pregnancy Outcome; D019851:Thrombophilia / Q000188:drug therapy* / Q000235:genetics; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight